AU1435997A - Xsns-type bi-functional sulphide-containing sulphonamide chelating agents for radioactive isotopes - Google Patents

Xsns-type bi-functional sulphide-containing sulphonamide chelating agents for radioactive isotopes

Info

Publication number
AU1435997A
AU1435997A AU14359/97A AU1435997A AU1435997A AU 1435997 A AU1435997 A AU 1435997A AU 14359/97 A AU14359/97 A AU 14359/97A AU 1435997 A AU1435997 A AU 1435997A AU 1435997 A AU1435997 A AU 1435997A
Authority
AU
Australia
Prior art keywords
xsns
sulphide
functional
type
chelating agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU14359/97A
Inventor
Ludger Dinkelborg
Sebastian Erber
Christoph Stephan Hilger
Wolfgang Kramp
Johannes Dr. Platzek
Bernd Dr. Raduchel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Institut fuer Diagnostikforschung GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut fuer Diagnostikforschung GmbH filed Critical Institut fuer Diagnostikforschung GmbH
Publication of AU1435997A publication Critical patent/AU1435997A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57536—Endothelin, vasoactive intestinal contractor [VIC]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0478—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group complexes from non-cyclic ligands, e.g. EDTA, MAG3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0497—Organic compounds conjugates with a carrier being an organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/004—Acyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/64—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and sulfur atoms, not being part of thio groups, bound to the same carbon skeleton
    • C07C323/67—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and sulfur atoms, not being part of thio groups, bound to the same carbon skeleton containing sulfur atoms of sulfonamide groups, bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F13/00—Compounds containing elements of Groups 7 or 17 of the Periodic System
    • C07F13/005—Compounds without a metal-carbon linkage
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/05—Isotopically modified compounds, e.g. labelled
AU14359/97A 1995-09-21 1996-09-19 Xsns-type bi-functional sulphide-containing sulphonamide chelating agents for radioactive isotopes Abandoned AU1435997A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19536781 1995-09-21
DE1995136781 DE19536781A1 (en) 1995-09-21 1995-09-21 Bifunctional sulfide-containing sulfonamide chelating agents of the type XSNS for radioactive isotopes
PCT/DE1996/001821 WO1997010852A2 (en) 1995-09-21 1996-09-19 Xsns-type bi-functional sulphide-containing sulphonamide chelating agents for radioactive isotopes

Publications (1)

Publication Number Publication Date
AU1435997A true AU1435997A (en) 1997-04-09

Family

ID=7773888

Family Applications (1)

Application Number Title Priority Date Filing Date
AU14359/97A Abandoned AU1435997A (en) 1995-09-21 1996-09-19 Xsns-type bi-functional sulphide-containing sulphonamide chelating agents for radioactive isotopes

Country Status (5)

Country Link
EP (1) EP0853488A2 (en)
AU (1) AU1435997A (en)
CA (1) CA2232391A1 (en)
DE (1) DE19536781A1 (en)
WO (1) WO1997010852A2 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19652374A1 (en) * 1996-12-04 1998-06-10 Schering Ag Use of endothelin conjugates in therapy, new endothelin conjugates, agents containing them, and processes for their preparation
EP0946202B1 (en) * 1996-10-28 2003-09-10 Amersham Health AS Contrast agents
US6524553B2 (en) 1998-03-31 2003-02-25 Bristol-Myers Squibb Pharma Company Quinolone vitronectin receptor antagonist pharmaceuticals
AU5541799A (en) 1998-03-31 1999-11-29 Du Pont Pharmaceuticals Company Pharmaceuticals for the imaging of angiogenic disorders
US6548663B1 (en) 1998-03-31 2003-04-15 Bristol-Myers Squibb Pharma Company Benzodiazepine vitronectin receptor antagonist pharmaceuticals
US6537520B1 (en) 1998-03-31 2003-03-25 Bristol-Myers Squibb Pharma Company Pharmaceuticals for the imaging of angiogenic disorders
US6794518B1 (en) 1998-12-18 2004-09-21 Bristol-Myers Squibb Pharma Company Vitronectin receptor antagonist pharmaceuticals
US6569402B1 (en) 1998-12-18 2003-05-27 Bristol-Myers Squibb Pharma Company Vitronectin receptor antagonist pharmaceuticals
EP1140204A2 (en) 1998-12-18 2001-10-10 Du Pont Pharmaceuticals Company Vitronectin receptor antagonist pharmaceuticals
CA2349333A1 (en) 1998-12-18 2000-06-22 Du Pont Pharmaceuticals Company Vitronectin receptor antagonist pharmaceuticals
US6511649B1 (en) 1998-12-18 2003-01-28 Thomas D. Harris Vitronectin receptor antagonist pharmaceuticals
GB0105224D0 (en) 2001-03-02 2001-04-18 Nycomed Amersham Plc Improved peptide-chelate conjugates
WO2005044313A2 (en) * 2003-11-06 2005-05-19 Amersham Health As Conjugates of angiotensin ii and an imaging moiety

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4310999C2 (en) * 1993-03-31 1996-07-18 Diagnostikforschung Inst Bifunctional chalkogen atom-interrupted chelating agents of the type XN¶1¶S¶1¶X 'for radioactive isotopes and their metal complexes, processes for their preparation and pharmaceutical compositions containing them
DK0710228T3 (en) * 1993-07-19 1998-09-21 Resolution Pharm Inc Hydrazines with N3S configuration as radionuclide chelators
EP0724601A4 (en) * 1993-08-17 1999-02-03 Neorx Corp S 3n chelating compounds for the radiolabeling of ligands, anti-ligands or other proteins

Also Published As

Publication number Publication date
WO1997010852A2 (en) 1997-03-27
CA2232391A1 (en) 1997-03-27
DE19536781A1 (en) 1997-03-27
EP0853488A2 (en) 1998-07-22
WO1997010852A3 (en) 1997-08-28

Similar Documents

Publication Publication Date Title
EG21449A (en) Chelating agents for improved color fidelity
GB9412757D0 (en) Toner processes
GB9412728D0 (en) Toner processes
ZA967760B (en) Spool & wedge assembly
AU1260099A (en) Projection exposure system
GB2276510B (en) Copying system
HU9602461D0 (en) Optical projection system
AU1435997A (en) Xsns-type bi-functional sulphide-containing sulphonamide chelating agents for radioactive isotopes
IL113796A0 (en) Projector
AU8590391A (en) Projection welding
AU7384394A (en) Chelating compounds
EP0716326A3 (en) A projection lens
AU1300597A (en) N2s2-type bi-functional nicotinamide chelating agents for radioactive isotopes
AU1436197A (en) Bifunctional sulphide-containing sulphonamide s2ny-type chelate-forming agents for radioisotopes
GB2288034B (en) Projection optical system
GB2273682B (en) Fusing agent
AU4482693A (en) Toner cartridge
SG68602A1 (en) Toner cartridge
GB9404992D0 (en) Projection system
HK1014791A1 (en) Mechanism for connecting cartridge
AU126576S (en) Toner cartridge
EP0670523A4 (en) Photosensitive material for electrophotography.
AU1539997A (en) Bifunctional, sulphide-containing sulphonamide-chelating agents of xsny type for radioactive isotopes
AU128550S (en) Toner cartridge
SG67281A1 (en) Toner cartridge